bg
A

Akari Therapeutics (AKTX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Akari Therapeutics (AKTX)

Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activati... Read more

  • USD1.18
  • USD1.21
  • USD1.14
  • USD4.40
  • -17.00%
  • --
  • 18.08k
  • 40M
  • 0.85
  • -64.50%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.